| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Niagen Bioscience, Inc. | Director | Stock Option (right to buy) | 20,000 | 24 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NAGE | Niagen Bioscience, Inc. | 24 Jun 2025 | 1 | $0 | 4 | Director | 26 Jun 2025, 17:30 |
| NAGE | ChromaDex Corp. | 20 Jun 2024 | 1 | $0 | 4 | Director | 24 Jun 2024, 17:43 |
| NAGE | ChromaDex Corp. | 15 Jun 2023 | 1 | $0 | 4 | Director | 16 Jun 2023, 17:30 |
| NAGE | ChromaDex Corp. | 16 Jun 2022 | 1 | $0 | 4 | Director | 21 Jun 2022, 21:17 |
| NAGE | ChromaDex Corp. | 17 Jun 2021 | 1 | $0 | 4 | Director | 22 Jun 2021, 17:23 |